Companies
Truking Technology
RU-friendlyChina's leading pharma equipment maker — smart single-use bioreactors, filling lines, and integrated smart-factory solutions for injectable drug manufacturing.
- Country
- China
- Revenue
- ~CNY 2.5B
- Employees
- ~3,000 emp
NMPA GMP
CE
ISO 9001
Coverage
| CN | EU | US | |
|---|---|---|---|
| analytics-pat | ✓ | ✓ | ✓ |
| fill-finish-packaging | ✓ | ✓ | ✓ |
| upstream-bioreactors | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Founded | 2000 | truking.com |
| Headquarters | Changsha, China (with an additional operational headquarters in Germany) | marketscreener.com · truking.com |
| Headcount | over 9,000 employees worldwide | truking.com |
| Revenue | 5.76 billion CNY (FY 2025); 5.79 billion CNY (trailing twelve months as of March 31, 2026) | stockanalysis.com |
| Production site | Truking Technology Industrial Park, Ningxiang, Changsha, China; Germany (via Romaco Group) | truking.com |
| Regulatory approval | Products and systems are designed to meet various international standards including GMP, FDA, WHO, and EUGMP requirements. Specific products have obtained DMF filings with the US FDA. medium confidence | truking.com |
| Certification | The company has led the development of over 20 national industry product technical standards. The company was honored with the Governor's Quality Award of Hunan Province. medium confidence | truking.com |
Independent sources: marketscreener.com · stockanalysis.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Aseptic filling lines | fill-finish-packaging | Low | → |
| Aseptic isolators for pharma manufacturing | analytics-pat | Low | → |
| Automated visual inspection | fill-finish-packaging | Low | → |
| Single-use bioprocessing & modular factories | upstream-bioreactors | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.